Cargando…
Secondary sclerosing cholangitis as a complication of severe COVID‐19: A case report and review of the literature
This case of secondary sclerosing cholangitis (SSC‐CIP) emphasizes the need to provide follow‐up care for patients that have recovered from COVID‐19 in order to understand the complexity of SARS‐CoV‐2 associated sequela.
Autores principales: | Klindt, Caroline, Jensen, Björn‐Erik, Brandenburger, Timo, Feldt, Torsten, Killer, Alexander, Schimmöller, Lars, Antoch, Gerald, Senff, Tina, Hauka, Sandra, Timm, Jörg, Bahners, Bahne Hendrik, Seidl, Maximilian, Esposito, Irene, Luedde, Tom, Bode, Johannes G., Keitel, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142800/ https://www.ncbi.nlm.nih.gov/pubmed/34084492 http://dx.doi.org/10.1002/ccr3.4068 |
Ejemplares similares
-
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure
por: Keitel, Verena, et al.
Publicado: (2021) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020
por: Walker, Andreas, et al.
Publicado: (2020) -
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019) -
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany
por: Jensen, Bjoern, et al.
Publicado: (2021)